Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Marked, long-lasting neuroprotective effects demonstrated for NXY-059 in rats

July 29, 1999

FDA approves SB's Kytril for prevention of radiation-induced nausea and vomiting

July 29, 1999

Abbott prepares potent, selective neuronal nicotinic acetylcholine receptor ligands

July 29, 1999

Postischemic YM-872 investigated for neuroprotective effects in model of acute ischemic stroke

July 28, 1999

Warner-Lambert patents new series of dopamine D4 antagonists

July 28, 1999

Dopaminergic agents for schizophrenia and Parkinson's disease from AHP

July 28, 1999

FDA approves pediatric formulation of Topamax

July 28, 1999

Avant's complement-selectin inhibitor reduces brain damage in mouse model of stroke

July 28, 1999

Elan to develop Antegren for chronic treatment of MS

July 27, 1999

Dual antioxidant/nNOS inhibitor effective in animal models of cerebral ischemia and brain injury

July 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026